Market Overview:
The global amlodipine besylate market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of hypertension and heart diseases, rising geriatric population, and growing awareness about the benefits of amlodipine besylate. Based on type, the global amlodipine besylate market can be segmented into 2.5mg tablets, 5mg tablets, and 10mg tablets. The 2.5mg tablet segment is expected to account for the largest share of the global market in 2018 owing to its lower dosage as compared to other segments and wide availability across regions. However, with increasing awareness about health benefits associated with high-dose amlodipine besylate formulations, the 10mg tablet segment is projected to grow at a higher CAGR during the forecast period from 2018to 2030.
Product Definition:
Amlodipine besylate is a calcium channel blocker used to treat high blood pressure and chest pain. It relaxes the muscles in the walls of your blood vessels. This lowers the pressure inside the vessels, which improves blood flow and reduces heart rate.
2.5mg Tablets:
2.5mg Tablets is used for the treatment of hypertension and angina (chest pain) by decreasing the blood pressure and heart rate to normal levels. It works by opening up arteries that are constricted due to high blood pressure, cholesterol, or other medical conditions.
The color of 2.5MG tablets varies from yellow to orange-red depending on its formulation.
5mg Tablets:
5mg Tablets are used for the treatment of hypertension and angina (chest pain) by decreasing the blood pressure and heart rate. It is also used as an anti-clotting agent in patients with coronary artery disease. The medicine has a similar mechanism of action to that of a natural hormone -angiotensin II, which is produced by the body when it's unable to get enough oxygenated blood flow.
Application Insights:
High blood pressure was the largest application segment in 2017 and is expected to continue its dominance over the forecast period. The product has been proven effective in reducing blood pressure and thus, is being used extensively for this purpose. However, there are few side effects associated with amlodipine besylate such as dizziness, headache and stomach upset which may limit its usage in high doses.
The use of amlodipine besylate for treating heart diseases such as hypertension was observed to be highest during the year 2016-2017 when compared with previous years due to an increase in awareness regarding lifestyle modifications along with a rise in incidence of target diseases. Moreover, increasing adoption of these tablets by patients suffering from cardiac disorders on account of their low cost coupled with minimal adverse effects will drive growth further during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to high product consumption and favorable reimbursement policies for hypertension treatment in U.S., coupled with increasing awareness about lifestyle changes and access to care management programs for hypertension patients. In addition, launch of new products by manufacturers such as Amgen Inc.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast years due its low cost base along with presence of untapped opportunities in emerging countries such as China & India.
Growth Factors:
- Increasing prevalence of hypertension and other cardiovascular diseases: The global prevalence of hypertension is estimated to be around 1.13 billion in 2015 and is projected to reach 1.56 billion by 2025. This will create a large pool of patients who will require treatment, thereby driving the demand for amlodipine besylate drugs.
- Rising geriatric population: The global geriatric population (aged 65 years or above) is expected to grow from 524 million in 2010 to nearly 1.5 billion by 2050, creating a large pool of patients with age-related cardiovascular diseases that will need treatment with amlodipine besylate drugs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Amlodipine Besylate Market Research Report
By Type
2.5mg Tablets, 5mg Tablets, 10mg Tablets
By Application
High Blood Pressure, Heart Disease
By Companies
Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma, Upsher-Smith Laboratories, InvaGen Pharmaceuticals, Pfizer, Aurobindo Pharma, Lupin Pharmaceuticals, Zydus Pharmaceuticals, Oxford Pharm, Wockhardt, Epic Pharma, CR Pharmaceutical, Alkem Laboratories, MACLEODS
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Amlodipine Besylate Market Report Segments:
The global Amlodipine Besylate market is segmented on the basis of:
Types
2.5mg Tablets, 5mg Tablets, 10mg Tablets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
High Blood Pressure, Heart Disease
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Mylan
- Dr. Reddy's Laboratories
- Apotex
- Teva Pharmaceutical
- Cipla
- Hikma Pharmaceuticals
- Strides Pharma
- Upsher-Smith Laboratories
- InvaGen Pharmaceuticals
- Pfizer
- Aurobindo Pharma
- Lupin Pharmaceuticals
- Zydus Pharmaceuticals
- Oxford Pharm
- Wockhardt
- Epic Pharma
- CR Pharmaceutical
- Alkem Laboratories
- MACLEODS
Highlights of The Amlodipine Besylate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2.5mg Tablets
- 5mg Tablets
- 10mg Tablets
- By Application:
- High Blood Pressure
- Heart Disease
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amlodipine Besylate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Amlodipine besylate is a medication used to treat high blood pressure. It works by relaxing the blood vessels and reducing the amount of fluid that flows through them. This can lower your blood pressure enough to help reduce the risk of heart attack or stroke. Amlodipine besylate is usually taken once a day, with or without food.
Some of the major players in the amlodipine besylate market are Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma, Upsher-Smith Laboratories, InvaGen Pharmaceuticals, Pfizer, Aurobindo Pharma, Lupin Pharmaceuticals, Zydus Pharmaceuticals, Oxford Pharm, Wockhardt, Epic Pharma, CR Pharmaceutical, Alkem Laboratories, MACLEODS.
The amlodipine besylate market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Amlodipine Besylate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Amlodipine Besylate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Amlodipine Besylate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Amlodipine Besylate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Amlodipine Besylate Market Size & Forecast, 2020-2028
4.5.1 Amlodipine Besylate Market Size and Y-o-Y Growth
4.5.2 Amlodipine Besylate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 2.5mg Tablets
5.2.2 5mg Tablets
5.2.3 10mg Tablets
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 High Blood Pressure
6.2.2 Heart Disease
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Amlodipine Besylate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Amlodipine Besylate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 2.5mg Tablets
9.6.2 5mg Tablets
9.6.3 10mg Tablets
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 High Blood Pressure
9.10.2 Heart Disease
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 2.5mg Tablets
10.6.2 5mg Tablets
10.6.3 10mg Tablets
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 High Blood Pressure
10.10.2 Heart Disease
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 2.5mg Tablets
11.6.2 5mg Tablets
11.6.3 10mg Tablets
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 High Blood Pressure
11.10.2 Heart Disease
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 2.5mg Tablets
12.6.2 5mg Tablets
12.6.3 10mg Tablets
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 High Blood Pressure
12.10.2 Heart Disease
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 2.5mg Tablets
13.6.2 5mg Tablets
13.6.3 10mg Tablets
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 High Blood Pressure
13.10.2 Heart Disease
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Amlodipine Besylate Market: Competitive Dashboard
14.2 Global Amlodipine Besylate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Mylan
14.3.3 Dr. Reddy's Laboratories
14.3.4 Apotex
14.3.5 Teva Pharmaceutical
14.3.6 Cipla
14.3.7 Hikma Pharmaceuticals
14.3.8 Strides Pharma
14.3.9 Upsher-Smith Laboratories
14.3.10 InvaGen Pharmaceuticals
14.3.11 Pfizer
14.3.12 Aurobindo Pharma
14.3.13 Lupin Pharmaceuticals
14.3.14 Zydus Pharmaceuticals
14.3.15 Oxford Pharm
14.3.16 Wockhardt
14.3.17 Epic Pharma
14.3.18 CR Pharmaceutical
14.3.19 Alkem Laboratories
14.3.20 MACLEODS
